Holen Sie sich die Stockscreener-App
23.85
0.84%
0.20
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) with B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus - MarketBeat
Stifel Nicolaus Initiates Coverage on Olema Pharmaceuticals With Buy Rating - marketscreener.com
Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Will Olema Pharmaceuticals Inc. stock benefit from automationJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - mfd.ru
Stifel initiates Olema Pharmaceuticals stock with Buy rating, $48 target By Investing.com - Investing.com Canada
Olema Pharmaceuticals, Inc. Rings the Closing Bell - Nasdaq
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Olema Pharmaceuticals seeks NDA lead for biotech program - Traders Union
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Weekly Recap: Does Olema Pharmaceuticals Inc have pricing power2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Institutional Investors Control 63% of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) and Were Rewarded Last Week After Stock Increased 7.2% - 富途牛牛
Cancer index surges 72% as Terns, Olema lead gains - BioWorld MedTech
Investment Review: Is Olema Pharmaceuticals Inc stock trending bullishQuarterly Trade Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
Olema Pharmaceuticals to Present at Upcoming Investor Conferences in February 2026 - Quiver Quantitative
Breast cancer drug developer Olema lines up three investor talks - Stock Titan
Risks Report: Whats next for Olema Pharmaceuticals Inc stockJuly 2025 Setups & Growth Focused Investment Plans - baoquankhu1.vn
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5% - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap DownTime to Sell? - MarketBeat
A Look At Olema Pharmaceuticals (OLMA) Valuation After Renewed Buy Ratings And Phase 3 Breast Cancer Plans - Sahm
Breakout Zone: How much upside does Olema Pharmaceuticals Inc haveJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
Trend Recap: What are analysts price targets for Olema Pharmaceuticals IncEarnings Miss & Fast Moving Stock Watchlists - baoquankhu1.vn
Olema Oncology CFO Shane Kovacs to depart after six-year tenure By Investing.com - Investing.com India
Olema CFO Exit Puts Focus On Palazestrant Plans And Cash Discipline - Yahoo Finance
Olema Oncology CFO Shane Kovacs to depart after six-year tenure - Investing.com Australia
Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role - Investing.com Nigeria
Olema Pharmaceuticals stock falls after CFO announces departure By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock falls after CFO announces departure - Investing.com
Olema Pharmaceuticals (OLMA) Executive Leadership Shift - GuruFocus
Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role - TipRanks
Olema Pharmaceuticals Chief Operating and Financial Officer Shane Kovacs Departs - marketscreener.com
Olema Oncology Announces Departure of Chief Operating and Financial Officer - The Manila Times
Olema (NASDAQ: OLMA) CFO exits with $621,283 package as CEO steps in - Stock Titan
Olema Oncology announces departure of chief operating and financial officer - marketscreener.com
Breast cancer-focused Olema sees financial officer depart, CEO steps in - stocktitan.net
LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) - Finviz
10 Best Small-Cap Stocks Ready to Explode in 2026 - Insider Monkey
Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next - TechStock²
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% HigherHere's What Happened - MarketBeat
Should I invest in Olema Pharmaceuticals Inc. before earningsGap Down & High Conviction Trade Alerts - mfd.ru
SEC Enforcement Action Targets Insider Trading in the Pharmaceutical Industry - akingump.com
Aug Outlook: Does Olema Pharmaceuticals Inc have pricing power2025 Geopolitical Influence & High Conviction Trade Alerts - baoquankhu1.vn
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up - TipRanks
Harmon Cyrus, director at Olema, sells $268,800 in stock By Investing.com - Investing.com UK
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares - MarketBeat
Harmon Cyrus, director at Olema, sells $268,800 in stock - Investing.com
0.07%
1.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):